{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T13:31:25Z","timestamp":1746538285042,"version":"3.30.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.repc.2024.04.010","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T16:05:09Z","timestamp":1720454709000},"page":"645-656","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mesenchymal stem cells may alleviate angiotensin II-induced myocardial fibrosis and hypertrophy by upregulating SFRS3 expression"],"prefix":"10.1016","volume":"43","author":[{"given":"Ling","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenbin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yundi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huogen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2024.04.010_bib0260","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbrc.2021.03.042","article-title":"Asenapine maleate inhibits angiotensin II-induced proliferation and activation of cardiac fibroblasts via the ROS\/TGF\u03b21\/MAPK signaling pathway","volume":"553","author":"Wu","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.repc.2024.04.010_bib0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41419-020-2243-4","article-title":"TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-\u03b21\/Smads and activating P53 signaling pathways","volume":"1","author":"Gao","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.repc.2024.04.010_bib0270","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1038\/s41467-019-11551-9","article-title":"WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling","volume":"1","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.repc.2024.04.010_bib0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/eurheartj\/ehx261","article-title":"IL-18 cleavage triggers cardiac inflammation and fibrosis upon \u03b2-adrenergic insult","volume":"1","author":"Xiao","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2024.04.010_bib0280","doi-asserted-by":"crossref","first-page":"e0178530","DOI":"10.1371\/journal.pone.0178530","article-title":"Enhanced expression and phosphorylation of Sirt7 activates smad2 and ERK signaling and promotes the cardiac fibrosis differentiation upon angiotensin-II stimulation","volume":"6","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.repc.2024.04.010_bib0285","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.117.027889","article-title":"Interleukin-10 inhibits bone marrow fibroblast progenitor cell-mediated cardiac fibrosis in pressure-overloaded myocardium","volume":"10","author":"Verma","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2024.04.010_bib0290","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target?","volume":"13","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2024.04.010_bib0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12659\/MSMBR.900437","article-title":"Cardiac hypertrophy: an introduction to molecular and cellular basis","volume":"22","author":"Samak","year":"2016","journal-title":"Med Sci Monit Basic Res"},{"key":"10.1016\/j.repc.2024.04.010_bib0300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/cvr\/cvu013","article-title":"Pregnancy as a cardiac stress model","volume":"4","author":"Chung","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.repc.2024.04.010_bib0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/heartjnl-2011-300639","article-title":"Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms","volume":"1","author":"Ellison","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.repc.2024.04.010_bib0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pcad.2009.05.002","article-title":"Clinical impact of left ventricular hypertrophy and implications for regression","volume":"2","author":"Artham","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.repc.2024.04.010_bib0315","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11906-013-0370-3","article-title":"Left ventricular hypertrophy in hypertensive children and adolescents: predictors and prevalence","volume":"5","author":"Kavey","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.repc.2024.04.010_bib0320","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"8","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.repc.2024.04.010_bib0325","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","article-title":"Roles of cardiac transcription factors in cardiac hypertrophy","volume":"10","author":"Akazawa","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.repc.2024.04.010_bib0330","first-page":"262","article-title":"Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy","volume":"4","author":"Kohli","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.repc.2024.04.010_bib0335","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.yjmcc.2015.12.016","article-title":"Transcriptional control of cardiac fibroblast plasticity","volume":"91","author":"Lighthouse","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.repc.2024.04.010_bib0340","doi-asserted-by":"crossref","first-page":"828549","DOI":"10.3389\/fphar.2022.828549","article-title":"Transcription factors involved in the development and prognosis of cardiac remodeling","volume":"13","author":"Hong","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.repc.2024.04.010_bib0345","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacbts.2018.05.003","article-title":"Epigenetics in cardiac fibrosis: emphasis on inflammation and fibroblast activation","volume":"5","author":"Felisbino","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.repc.2024.04.010_bib0350","article-title":"Roles of epigenetics in cardiac fibroblast activation and fibrosis","volume":"15","author":"Shao","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.repc.2024.04.010_bib0355","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacbts.2019.05.011","article-title":"Epigenetics in cardiac hypertrophy and heart failure","volume":"8","author":"Liu","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.repc.2024.04.010_bib0360","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s10741-020-09959-3","article-title":"The role and molecular mechanism of epigenetics in cardiac hypertrophy","volume":"6","author":"Lei","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.repc.2024.04.010_bib0365","article-title":"Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells","volume":"2","author":"Karpov","year":"2017","journal-title":"Cell Prolif"},{"key":"10.1016\/j.repc.2024.04.010_bib0370","doi-asserted-by":"crossref","first-page":"28250","DOI":"10.1038\/srep28250","article-title":"Bone marrow mesenchymal stem cells (BM-MSCs) improve heart function in swine myocardial infarction model through paracrine effects","volume":"6","author":"Cai","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.repc.2024.04.010_bib0375","doi-asserted-by":"crossref","first-page":"19155","DOI":"10.1038\/srep19155","article-title":"Intracoronary transplantation of mesenchymal stem cells with overexpressed integrin-linked kinase improves cardiac function in porcine myocardial infarction","volume":"6","author":"Mu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.repc.2024.04.010_bib0380","first-page":"21","article-title":"Biological function and molecular mechanism of SRSF3 in cancer and beyond","volume":"1","author":"Xiong","year":"2022","journal-title":"Oncol Lett"},{"key":"10.1016\/j.repc.2024.04.010_bib0385","doi-asserted-by":"crossref","first-page":"577636","DOI":"10.3389\/fonc.2020.577636","article-title":"Emerging roles of SRSF3 as a therapeutic target for cancer","volume":"10","author":"Zhou","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.repc.2024.04.010_bib0390","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0960-9822(99)80394-7","article-title":"Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20","volume":"16","author":"Jumaa","year":"1999","journal-title":"Curr Biol"},{"key":"10.1016\/j.repc.2024.04.010_bib0395","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ncomms2342","article-title":"Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function","volume":"4","author":"Sen","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.repc.2024.04.010_bib0400","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7150\/ijbs.6.806","article-title":"SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance","volume":"7","author":"Jia","year":"2010","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.repc.2024.04.010_bib0405","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1111\/jcmm.17539","article-title":"miR-486 improves fibrotic activity in myocardial infarction by targeting SRSF3\/p21-mediated cardiac myofibroblast senescence","volume":"20","author":"Chen","year":"2022","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.repc.2024.04.010_bib0410","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.118.314515","article-title":"Loss of SRSF3 in cardiomyocytes leads to decapping of contraction-related mRNAs and severe systolic dysfunction","volume":"2","author":"Ortiz-Sanchez","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.repc.2024.04.010_bib0415","first-page":"e21544","article-title":"Cardiomyocyte-specific Srsf3 deletion reveals a mitochondrial regulatory role","volume":"5","author":"Dumont","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.repc.2024.04.010_bib0420","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/gtc.12055","article-title":"Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16","volume":"7","author":"Matsumoto","year":"2013","journal-title":"Genes Cells"},{"key":"10.1016\/j.repc.2024.04.010_bib0425","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.bbadis.2019.01.019","article-title":"Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1","volume":"6","author":"Li","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.repc.2024.04.010_bib0430","doi-asserted-by":"crossref","first-page":"29717","DOI":"10.1074\/jbc.M003128200","article-title":"Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes","volume":"38","author":"Sano","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.repc.2024.04.010_bib0435","doi-asserted-by":"crossref","first-page":"e35144","DOI":"10.1371\/journal.pone.0035144","article-title":"Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta\/Smad activation and cardiac fibrosis induced by angiotensin II","volume":"5","author":"Ma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.repc.2024.04.010_bib0440","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCHEARTFAILURE.114.001893","article-title":"Tumor necrosis factor: a mechanistic link between angiotensin-II-induced cardiac inflammation and fibrosis","volume":"2","author":"Duerrschmid","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.repc.2024.04.010_bib0445","article-title":"Galectin-3 in cardiovascular diseases","volume":"23","author":"Blanda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.repc.2024.04.010_bib0450","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bone.2012.01.006","article-title":"Stanniocalcin 2 is associated with ectopic calcification in \u03b1-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells","volume":"4","author":"Takei","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.repc.2024.04.010_bib0455","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fphys.2017.00268","article-title":"Chronic endurance exercise impairs cardiac structure and function in middle-aged mice with impaired Nrf2 signaling","volume":"8","author":"Shanmugam","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.repc.2024.04.010_bib0460","article-title":"Modulation of fatty acid-related genes in the response of H9c2 cardiac cells to palmitate and n-3 polyunsaturated fatty acids","volume":"3","author":"Cetrullo","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.repc.2024.04.010_bib0465","first-page":"e153","article-title":"Heart disease and stroke statistics \u2013 2022 update: a report from the American Heart Association","volume":"8","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2024.04.010_bib0470","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"25","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2024.04.010_bib0475","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10557-015-6607-4","article-title":"The challenges of prevention, diagnosis and treatment of ischemic heart disease in women","volume":"4","author":"Brewer","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.repc.2024.04.010_bib0480","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"11","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2024.04.010_bib0485","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress","volume":"4","author":"Pittenger","year":"2019","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.repc.2024.04.010_bib0490","doi-asserted-by":"crossref","first-page":"1003684","DOI":"10.3389\/fphar.2022.1003684","article-title":"Stem cell-derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy \u2013 in a model of human-induced pluripotent stem cell-derived cardiomyocytes","volume":"13","author":"Constantin","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.repc.2024.04.010_bib0495","doi-asserted-by":"crossref","first-page":"5720758","DOI":"10.1155\/2016\/5720758","article-title":"Pathological left ventricular hypertrophy and stem cells: current evidence and new perspectives","volume":"2016","author":"Marketou","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.repc.2024.04.010_bib0500","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","article-title":"Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy","volume":"14","author":"Fan","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.repc.2024.04.010_bib0505","doi-asserted-by":"crossref","first-page":"35976","DOI":"10.1038\/srep35976","article-title":"HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells","volume":"6","author":"Jia","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.repc.2024.04.010_bib0510","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/cdd.2013.171","article-title":"Splicing factor SRSF3 represses the translation of programmed cell death 4 mRNA by associating with the 5\u2032-UTR region","volume":"3","author":"Kim","year":"2014","journal-title":"Cell Death Differ"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S087025512400221X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S087025512400221X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T11:40:09Z","timestamp":1733053209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S087025512400221X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S087025512400221X"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2024.04.010","relation":{},"ISSN":["0870-2551"],"issn-type":[{"type":"print","value":"0870-2551"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cells may alleviate angiotensin II-induced myocardial fibrosis and hypertrophy by upregulating SFRS3 expression","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2024.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}